# Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season

> **NCT01633749** · PHASE3 · COMPLETED · sponsor: **Abbott Biologicals** · enrollment: 120 (actual)

## Conditions studied

- Prophylaxis of Influenza

## Interventions

- **BIOLOGICAL:** Trivalent influenza subunit vaccine Influvac

## Key facts

- **NCT ID:** NCT01633749
- **Lead sponsor:** Abbott Biologicals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01633749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01633749, "Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01633749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*